add-x diabetes nillitus


Published on

dm slide

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Aim: Very basic introduction to diabetes for an audience that may not know a great deal about the disease area. NB can refer them back to their press packs which have detailed background information on diabetes and complications
  • There is a temporal relationship between insulin resistance, insulin secretion and the development of diabetes. In the early stages, as insulin resistance rises, there is a compensatory increase in insulin secretion and the individual remains normoglycemic. In the long term, as the  -cells begin to fail, insulin secretion falls, abnormal glucose tolerance and hyperglycemia become apparent and frank type 2 diabetes develops. International Diabetes Center (IDC), Minneapolis, Minnesota.
  • Stepwise approach The traditional stepwise approach aims primarily to control acute symptoms. Dietary measures and exercise are not usually sufficient to control glycemia beyond the first year of therapy. If oral monotherapy proves inadequate, combination therapy is usually started. If this also proves unsuccessful, conversion to insulin is the next step, either alone or in combination with an oral agent. In the majority of cases, the stepwise approach does not lead to sustained control. Many physicians intensify treatment only when symptoms of poor glycemic control become apparent, rather than when glycemic targets are not reached. Early, aggressive approach This approach to type 2 diabetes management avoids the risk of early treatment failure by adopting an intensive therapeutic strategy immediately upon diagnosis. Combinations of agents with complementary modes of action targeting the dual defects underlying type 2 diabetes (insulin resistance and b-cell dysfunction) are most likely to support tight, long-term glycemic control. Furthermore, combination therapy should be considered earlier in the regimen to provide additional glycemic control. Campbell IW. Br J Cardiol 2000; 7 :625–631.
  • Aim: To show why A1c control is important relating level to complications: Good glycaemic control is essential to reduce the risk of diabetic complications Based on the Diabetes Control and Complications Trial data that compared conventional with intensive regimens , the relative risk for microvascular complications such as diabetic retinopathy, nephropathy, neuropathy, and microalbuminuria increases with increasing levels of A1C 1-3 The relative risk of complications is set to “1” for an A1C of 6% 1 It is important to note that the risk gradient is continuous with no glycaemic threshold for developing complications 1 1. Skyler JS. Diabetic complications: the importance of glucose control. Endocrinol Metab Clin North Am . 1996;25:243-254. 2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitis. N Engl J Med . 1993;329:977-986. 3. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA 1C ) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes . 1995;44:968-983.
  • add-x diabetes nillitus

    1. 1. Diabetes Mellitus Prof Seamus SreenanDept of Diabetes and Endocrinology,Connolly Hospital, Blanchardstown Mini Med School November 30th, 2011
    2. 2. Learning Objectives At the end of this talk you should understand: – What diabetes mellitus means – The difference between types-1 and -2 diabetes – How the different types are treated – The reasons for the current epidemic of diabetes and how it can be prevented – What the complications of diabetes are and how they can be prevented
    3. 3. What is Diabetes?Diabetes Mellitus (sugar diabetes) is adisease characterized by high levels ofsugar (glucose) in the bloodFasting glucose ≥ 7.0 (mmol/L)
    4. 4. Blood sugar and healthSugar (glucose) isan important source Insulin is producedof energy by the pancreas when blood sugar is highWhat is eaten isabsorbed into Insulin keeps bloodthe blood sugar level within the normal range for health
    5. 5. Islet of Langerhans:Pancreas containsinsulin-makingcells in “islets” Insulin β-cells
    6. 6. Diabetes in a ‘nutshell’ Insufficient insulin to meet the body’s needs Either a complete lack (type 1) or relative lack (type 2) Results in raised blood glucose levels Untreated diabetes results in short-term symptoms and serious long-term complications Treatment aims to keep blood glucose levels as close to the normal range as safely possible
    7. 7. Complications of Diabetes Short term: – Symptoms of diabetes – Dehydration – Diabetic Coma – Infections Long term: – Kidney – Eye – Heart – Circulation – Amputation
    8. 8. Symptoms of DiabetesPeople with diabetes often have typical complaints(symptoms): Thirst and frequent drinking More frequent urination, particularly at night Unexplained weight loss Fatigue Blurred vision Frequent infections : skin, genital
    9. 9. Case 1 JN 32 year old male Referred to Emergency Dept by GP Complaining of thirst, excessive urination, half stone weight loss in the last 6 weeks No relevant past history First cousin has diabetes on insulin On no regular medications Thin man Blood sugar level = 24.7 mmol/L
    10. 10. What type of diabetes does JN have?There are 2 main types of diabetes: Type 1 (15%): Due to total lack of insulin – insulintreatment is required for life Type 2 (85%): Plenty of insulin which does not work very well in the body. Insulin treatment may berequired at some stage but is not required in all patients
    11. 11. Differences between type-1 and type-2 Diabetes Mellitus Type 1  Type 2 Young age  Middle aged, elderly Normal BMI, not obese  Usually overweight/obese No immediate family  Family history usual history  Symptoms may be present Short duration of for months/years symptoms (weeks)  Do not present with Can present with diabetic diabetic coma coma (diabetic  Insulin not necessarily ketoacidosis) required Insulin required  Previous diabetes in pregnancy These differences are not absolute
    12. 12. JN Young age Thin No immediate family history Short duration of symptomsAll point to probable type-1 diabetes Insulin treatment required
    13. 13. The Miracle of InsulinPatient J.L., December 15, February 15, 19231922
    14. 14. Treatment of Type-1 Diabetes Mellitus:  Insulin must be administered into the subcutaneous pocket between fat & muscle & avoid injection into fat or muscle.  Can be administered by needle and syringe or by pen device
    15. 15. Alternative way to deliver insulin treatment:Continuous insulin infusion (insulin pump)
    16. 16. Islet replacement treatment Aim to replace the need for insulin treatment (Kidney) Pancreas transplantation Islet transplantation – not available in Ireland Anti-rejection drugs required Stem cell transplantation - experimental
    17. 17. Case 2 Ms AJ, a 45 year old woman is concerned she may have diabetes She had diabetes during her last pregnancy managed with diet Lately she has been feeling tired but otherwise has no complaints Her mother and one of her two sisters already have diabetes treated with tablets She has been overweight since her last pregnancy and has taken a tablet for blood pressure for the last 2 years She is obese, body mass index 34.5 Blood pressure is 140/90 but otherwise her examination is normal She undergoes a testing and her fasting glucose is 9.4 mmol/L Obese, strong family history, aged in 40s, previous history of diabetes in pregnancy all point to type-2 diabetes
    18. 18. Natural History of Type 2 Diabetes Normal Prediabetes Type 2 diabetes Insulin Increasing insulin resistance resistance Insulin Hyperinsulinemia, secretion then islet cell failureAfter meal Abnormal glucose glucose tolerance Fasting High sugar levels glucose Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota.
    19. 19. Treatment of Type-2 Diabetes Diet/ Oral Oral Oral Insulin exercise monotherapy combination +/- insulinDiet and exercise my control condition for some timeVariety of tablets available when diet exercise no longer workTablets can be used in combination with each other or withinsulinInsulin can also be used alone
    20. 20. Prevalence of Diabetes Diabetes is very common It is becoming more common(particularly type-2) It affects about 200,000 Irish people 10% of the health budget spent ondiabetes
    21. 21. Reason for increasing prevalence of type-2 diabetesThe disease is reaching epidemic proportionsbecause: Rates of overweight/obesity have increased We have become a physically inactive species Our diets are increasingly unhealthy
    22. 22. Overweight and obesity are diagnosed bymeasuring weight and height (Body MassIndex (BMI)): Weight in Kg BMI = Height in metres2Normal = 20-25Overweight = 25-30Obese = more than 30Everyone should know their BMI!
    23. 23. Can Diabetes be Prevented?To be able to prevent a disease we need to be able toindentify people at particular risk of developing it
    24. 24. Risk factors for type 2 diabetesCertain people are more at risk of diabetes: Those who are overweight/obese People with a family history of diabetes Women who had diabetes during pregnancy orhave had a baby weighing more than 9lbs Physically inactive people Certain ethnic groups (african, american indian,asian) People who have high blood pressure or highcholesterol Age more than 45 years
    25. 25. Can Diabetes be Prevented?Risk of Type 2 Diabetes can be reduced: Losing weight Taking regular exercise : walking for 30 mins per day Eating healthier food:  Less fat (burgers, fries, crisps, sweet foods)  More fibre (fruit and vegetables, wholegrain alternatives for rice, bread) Cutting down on alcohol consumption Ultimate aim is to reduce the longterm complications
    26. 26. Can the longterm complications be prevented? Type-1 – 1993: Study showed for the first time that good sugar control can prevent long term complications affecting eyes/kidneys/nerves Type-2 – 1998: Similar study showed same conclusion for type-2 Importanttherefore to know that sugar control is good and monitor frequently
    27. 27. Diabetes Mellitus: Self Monitoring SMBG  Patients can draw blood frequently to monitor their glucose levels. A glucose monitor is used to check the sugar as required
    28. 28. Glycosylated Hemoglobin: HbAlc Blood test that measures the amount of glucose that has been incorporated into the hemoglobin protein of the red blood cell (RBC). Reflects the lifespan of a RBC, so test will reveal the effectiveness of diabetes therapy for the preceding 8-12 weeks. HbA1c levels remain more stable than sugar levels. Not affected by short-term fluctuations in sugar Normal is 4-6% Evaluated periodically (1-2 per year if well controlled, more frequently if not)
    29. 29. A1c and relative risk of complications (type 1 diabetes) : 20 Retinopathy 15 Nephropathy NeuropathyRelative Risk (%) 13 Microalbuminuria Aim for AIc of < 7% 11 9 7 5 3 1 6 7 8 9 10 11 12 A1c (%) DCCT, Diabetes Control and Complications Trial. 1. Adapted from Skyler JS. Endocrinol Metab Clin North Am. 1996;25:243-254. 2. DCCT. N Eng J Med. 1993;329:977-986. 3. DCCT. Diabetes. 1995;44:968-983.
    30. 30. How to prevent the complicationsFactors other than blood sugar increase likelihood ofcomplications and should be managedComplications can be delayed/prevented by: Controlling blood sugars: sticking to diet/exerciseprogramme, taking medication as prescribed Controlling blood pressure: diet, salt restriction,medication Controlling cholesterol levels: diet, statin tablets Stopping smoking Taking aspirin?
    31. 31. Useful websites Diabetes Federation of Ireland: – American Diabetes Association – Irish Nutrition and Dietetic Institute – Juvenile Diabetes Research Foundation –